SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-23-058305
Filing Date
2023-03-02
Accepted
2023-03-02 17:03:12
Documents
6
Effectiveness Date
2023-03-02

Document Format Files

Seq Description Document Type Size
1 POSASR d468979dposasr.htm POSASR 257685
2 EX-5.1 d468979dex51.htm EX-5.1 17960
3 EX-23.2 d468979dex232.htm EX-23.2 2215
4 EX-24.2 d468979dex242.htm EX-24.2 3122
5 EX-FILING FEES d468979dexfilingfees.htm EX-FILING FEES 41137
6 GRAPHIC g468979g82g10.jpg GRAPHIC 28540
  Complete submission text file 0001193125-23-058305.txt   359545
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-263226 | Film No.: 23700127
SIC: 2834 Pharmaceutical Preparations